Acyltransferase Polynucleotide Detection

High-Sensitivity Acyltransferase Polynucleotide Detection for Gene Expression, Mutation Analysis, and Functional Genomics

Acyltransferases constitute a large and functionally diverse family of enzymes that catalyze the transfer of acyl groups from donors such as acyl-CoA or acyl-ACP to diverse acceptors, including glycerol-3-phosphate, lysophosphatidic acid, diacylglycerol, and sterols. These enzymes play central roles in lipid biosynthesis, membrane remodeling, energy storage, and signal transduction across all kingdoms of life. The detection and quantitation of acyltransferase-encoding polynucleotides—whether genomic DNA, complementary DNA, or messenger RNA—are fundamental to understanding their regulatory mechanisms, identifying disease-associated mutations, and engineering strains with altered lipid profiles. However, reliable detection of these nucleic acid targets is challenged by the high sequence homology among family members, the presence of pseudogenes, low transcript abundance in certain tissues, and the need for absolute specificity to discriminate between highly similar isoforms. Our specialized detection platform provides a comprehensive suite of nucleic acid assays—including real-time PCR (qPCR), digital PCR (dPCR), droplet digital PCR (ddPCR), and amplicon-based next-generation sequencing (NGS)—tailored to the precise identification and quantitation of acyltransferase polynucleotides. Whether the client is a metabolic engineer, a pharmaceutical researcher, a clinical diagnostician, or a crop scientist, our service delivers the sensitivity, specificity, and reproducibility required to advance research and development programs.

Scientific and Strategic Rationale for Acyltransferase Nucleic Acid Detection

Clients seeking acyltransferase polynucleotide detection services are driven by a range of objectives. In functional genomics and transcriptomics, the primary need is to quantify the expression levels of specific acyltransferase genes across different tissues, developmental stages, or treatment conditions to identify regulatory networks and rate-limiting steps in lipid metabolism. In genetic screening and mutation detection, the goal is to identify single nucleotide polymorphisms (SNPs), insertions, deletions, or copy number variations in acyltransferase genes that may be associated with inherited metabolic disorders, drug resistance, or desirable agronomic traits. In recombinant protein production, verification of transgene integration and copy number is essential to select high-expression clones. In diagnostic applications, detection of pathogen-derived acyltransferase genes (e.g., in mycobacteria or fungi) enables rapid and accurate identification of infectious agents. Furthermore, in quality control of cell and gene therapies, monitoring of acyltransferase expression or vector copy number is required for product release. Our service is architected to address these diverse needs with a flexible, fully validated analytical framework that adapts to the specific target, matrix, and throughput requirements.

Integrated Analytical Pipeline for Acyltransferase Polynucleotide Profiling

Our analytical platform is structured into three interconnected modules that collectively deliver comprehensive nucleic acid characterization. The Nucleic Acid Extraction and Quality Module employs automated magnetic-bead-based or silica-membrane extraction systems optimized for a wide range of sample types (cultured cells, tissues, blood, plasma, formalin-fixed paraffin-embedded samples, microbial cultures, and plant material). We provide quality assessment via microcapillary electrophoresis (e.g., Bioanalyzer or TapeStation) to determine RNA integrity number (RIN) or DNA integrity, ensuring that only high-quality templates are used for downstream assays, and we include removal of genomic DNA contamination for RNA samples. The Quantitative Detection Module utilizes dye-based or probe-based real-time PCR (TaqMan®) with primers and probes designed using proprietary algorithms that ensure >99% amplification efficiency and specificity against all known acyltransferase isoforms. We offer absolute quantification using standard curves from synthetic DNA or plasmid standards, and relative quantification using validated reference genes (e.g., GAPDH, ACTB, 18S rRNA), achieving LOQs as low as 1–10 copies per reaction and inter-assay coefficients of variation (CV) < 3%. For ultra-low copy number detection (e.g., circulating tumor DNA, liquid biopsies, or rare transcript detection), we employ droplet digital PCR (ddPCR) with a limit of detection down to 0.01 copies/µL, providing absolute quantitation without the need for standard curves and with superior tolerance to PCR inhibitors. The Sequence and Variant Module uses targeted amplicon sequencing (Illumina or Ion Torrent platforms) with read depths > 10,000× to detect rare variants (allelic frequency as low as 1%), and we provide full bioinformatics analysis including base calling, alignment, variant calling (SNPs, indels, splice variants), and annotation against reference databases (e.g., GenBank, Ensembl). For global transcriptome profiling, we offer RNA-seq with ≥ 20 million paired-end reads per sample, enabling quantification of all acyltransferase family members and their isoforms, as well as the discovery of novel splice variants or fusion transcripts. All modules are integrated with our LIMS system, and we provide full documentation of sample handling, extraction yields, and assay performance.

Unmatched Sensitivity, Specificity, and Reproducibility

Our platform delivers exceptional performance metrics. The TaqMan® assay designs include locked nucleic acid (LNA) modifications to enhance melting temperature and specificity, enabling the discrimination of single-base mismatches (e.g., distinguishing between highly homologous isoforms such as DGAT1 and DGAT2). In ddPCR, our optimized reaction partitioning generates > 20,000 droplets per sample, and the Poisson-based statistical analysis provides absolute copy number with a 95% confidence interval typically within ±10% at low concentrations. For sequencing, our bioinformatics pipeline incorporates quality filtering (Phred score > 30), duplicate removal, and stringent variant calling thresholds, resulting in false positive rates below 0.1%. We also perform multiplexed assays that allow simultaneous detection of up to 5 different acyltransferase targets in a single qPCR reaction, significantly reducing sample consumption and cost. Our standard operating procedures are validated for linear dynamic ranges spanning 6–8 orders of magnitude, and we include internal positive controls (IPC) and external quality controls (EQC) in every run to monitor for inhibitors and confirm reagent performance. This high level of analytical rigor ensures that our clients receive data with known accuracy and precision, enabling confident decision-making.

Distinctive Advantages of Our Acyltransferase Polynucleotide Detection Service

Our service provides several unique benefits. First, we have developed a proprietary primer and probe database covering over 400 acyltransferase genes from human, mouse, rat, pig, cow, chicken, zebrafish, yeast, and major plant species (Arabidopsis, rice, soybean, maize), enabling rapid deployment of assays for virtually any organism without the need for de novo design. Second, we offer custom assay design for novel or highly polymorphic acyltransferase targets, including design of allele-specific primers for SNP genotyping, and we validate each assay for specificity, efficiency, and linearity before reporting results. Third, we provide a rapid screening service using multiplexed endpoint PCR with capillary electrophoresis that delivers qualitative presence/absence or semi-quantitative assessment of up to 10 targets within 3 hours from DNA/RNA receipt. Fourth, our copy number variation (CNV) analysis using ddPCR enables precise determination of transgene copy number in genetically modified organisms or cell lines, with discrimination of 1, 2, 3, and 4 copy events, which is critical for selecting stable high-producers. Fifth, we offer comprehensive data interpretation including fold-change calculations with statistical significance (Student's t-test, ANOVA, with multiple testing correction), heatmap visualization of expression profiles, and pathway enrichment analysis when multiple acyltransferase targets are examined. Sixth, all our methods are accredited under ISO/IEC 17025 and comply with MIQE (Minimum Information for Publication of Quantitative Real-Time PCR Experiments) and guidelines for NGS-based diagnostic assays, and we provide full validation documentation including specificity, efficiency, precision, accuracy, linear range, LOD, LOQ, and robustness. Our team of molecular biologists and bioinformaticians provides consultative interpretation, helping clients to correlate expression changes with phenotypic or functional outcomes, and to design follow-up experiments.

Advanced Data Integration, Biostatistical Modeling, and Reporting

Our reporting transforms raw molecular data into meaningful biological insights. We deliver a comprehensive report that includes: (i) an executive summary with fold-change values, copy numbers, and variant calls, accompanied by graphical summaries (bar charts, scatter plots, and volcano plots); (ii) a detailed experimental section with amplification plots, standard curves, melting curves, quality control metrics (Cq values, RIN, etc.), and raw data tables; (iii) a statistical analysis section with p-values, confidence intervals, and sample clustering if applicable; and (iv) a biological interpretation that explains the significance of the results in the context of the client's research or production goals. For multi-experiment projects, we provide principal component analysis (PCA) and hierarchical clustering to reveal patterns across groups. We also offer predictive modeling of expression levels based on experimental variables (e.g., treatment dose, time) using linear or non-linear regression. All raw data (amplification curves, .fastq files, .bam files, variant call format files) are included for full transparency and re-analysis. Our reports are formatted for publication in peer-reviewed journals and for submission to regulatory agencies.

Broad Applications Across Metabolic Engineering, Clinical Research, AgBiotech, and Drug Discovery

The versatility of our acyltransferase polynucleotide detection service spans multiple sectors. In metabolic engineering and synthetic biology, our assays support the optimization of microbial strains for lipid production (e.g., fatty acid ethyl esters, triglycerides). In pharmaceutical research, we quantify acyltransferase expression in drug-treated cells to understand mechanisms of action and potential toxicity. In clinical diagnostics, we detect mutations in acyltransferase genes (e.g., DGAT1 variants associated with congenital diarrhea or metabolic syndrome) from patient samples. In crop biotechnology, we verify the integration and expression of acyltransferase transgenes for enhanced oil content or altered fatty acid composition. In veterinary and aquaculture, we monitor lipid metabolism gene expression in response to dietary interventions. In environmental microbiology, we detect acyltransferase genes as biomarkers for microbial community function. Our adaptability to a wide range of matrices and targets ensures that we serve a diverse global clientele with specialized needs.

Commitment to Innovation, Quality, and Collaborative Research

We are dedicated to maintaining leadership in nucleic acid detection through continuous methodological improvement. Our current R&D includes the development of CRISPR-based nucleic acid detection platforms (e.g., SHERLOCK, DETECTR) for rapid, isothermal detection of acyltransferase nucleic acids without thermocycling, and the implementation of single-cell RNA-seq to profile acyltransferase expression at the cellular level. We actively participate in inter-laboratory proficiency testing for gene expression and mutation detection, and we contribute to the development of reference materials for acyltransferase genes. Our quality system is ISO 17025 and ISO 13485 certified (for diagnostic services), and we follow GLP for all studies. We offer flexible engagement models, from single-sample analysis to high-throughput screening of hundreds of samples, with dedicated project management, volume pricing, and priority handling. Our global logistics ensure safe shipment of nucleic acid samples (e.g., RNA in RNA-stabilizing solutions, DNA at ambient temperature) with clear instructions. Turnaround times range from 2 business days for qPCR-based single-target assays to 15 business days for full transcriptome sequencing and analysis. We maintain open communication, providing project updates and expert advice throughout. Our success is measured by the progress our clients make in their research and development. We invite you to partner with us to unlock the molecular insights of acyltransferase biology with confidence and precision.

In summary, our acyltransferase polynucleotide detection service delivers a comprehensive, precise, and regulation-ready analytical solution that integrates high-efficiency nucleic acid extraction, validated real-time PCR and ddPCR, and advanced sequencing technologies. By providing sensitive and specific quantitation and variant detection, coupled with expert bioinformatic interpretation, we empower our clients to accelerate discovery, optimize bioprocesses, and ensure product quality. We look forward to supporting your nucleic acid analysis needs with our dedicated molecular expertise.